James O. Hearty, an insider at DaVita Inc (DVA), purchased 31,913 shares of the company on December 3, 2025, at a price of $108.93 per share, resulting in a total transaction value of $3.48 million. Following this transaction, Hearty holds a total of 31,913 shares in the company.
DaVita Inc, headquartered in Denver, Colorado, is a prominent provider of kidney care services in the United States. The firm employs 76,000 full-time staff and operates a robust platform that includes established nephrology and payor relationships. Its U.S. dialysis business treats patients with chronic kidney failure and end-stage kidney disease (ESKD), while its integrated kidney care (IKC) division offers disease management services to patients across various risk-based arrangements.
As of December 4, 2025, DaVita has a market capitalisation of $8.3 billion, with a P/E ratio of 10.78 and an EPS of 9.71. The company is set to report its next earnings on August 3, 2026, with an estimated EPS of $3.34 and revenue of $3.5 billion.
Insider transactions, while informative, should be viewed as one data point among many. Investors are encouraged to consider broader patterns of insider activity and other fundamental factors when assessing corporate health.